La proflaxis antitrombótica: esencial para la seguridad de los pacientes

Jaimovich, David
July 2010
Cirugia y Cirujanos;jul/ago2010, Vol. 78 Issue 4, p293
Academic Journal
No abstract available.


Related Articles

  • La proflaxis antitrombótica: esencial para la seguridad de los pacientes. Jaimovich, David // Cirugia y Cirujanos;jul/ago2010, Vol. 78 Issue 4, p293 

    No abstract available.

  • Pulmonary Embolism.  // Current Medical Literature: Respiratory Medicine;2006, Vol. 20 Issue 1, p9 

    Presents abstracts of articles on pulmonary embolism. "Efficacy of Thrombolytic Agents in the Treatment of Pulmonary Embolism," by T. Capstick and M. T. Henry; "Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension," by M. M. Hoeper, T. Kramm, H. Wilkins et al; "The...

  • The Prevention of Venous Thromboembolism in Older Adults: Guidelines. Aronow, Wilbert S. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jan2004, Vol. 59 Issue 1, p42 

    The rationale for thromboprophylaxis is based on the high prevalence of venous thromboembolism (VTE), a disorder involving deep vein thrombosis (DVT) and pulmonary embolism (PE), among hospitalized patients, the clinically silent nature of VTE in most patients, and the morbidity, cost, and...

  • FIBRINOLYSIN THERAPY OF THROMBOEMBOLISM: THREE YEARS' EXPERIENCE. Sheffer, Albert L.; Lisker, Samuel; Nemir Jr., Paul // Angiology;May1961, Vol. 12 Issue 5, p165 

    The clinical evaluation of 67 patients treated with fibrinolysin is presented. Thirty-three cases reported previously are added for follow-up purposes. Thrombophlebitis, pulmonary embolism, vascular surgery and ophthalmologic experience are described. There are a few encouraging examples in each...

  • Thromboembolism in heart failure, old ideas and new challenges. Isnard, Richard; Komajda, Michel // European Journal of Heart Failure;Jun2001, Vol. 3 Issue 3, p265 

    Until now, the administration of antithrombotic therapy in patients with congestive heart failure has not been well codified. The incidence of thromboembolic complication, such as stroke, peripheral or pulmonary embolism, is regarded as too low to justify the use of anticoagulation in...

  • Primary Prophylaxis of Venous Thromboembolism in Surgical Patients. Rawat, Anish; Huynh, Tam T.; Peden, Eric K.; Kougias, Panagiotis; Lin, Peter H. // Vascular & Endovascular Surgery;Jun/Jul2008, Vol. 42 Issue 3, p205 

    Venous thromboembolism is a major risk for surgical patients during the perioperative period. Prevention of perioperative venous thromboembolism remains a critical component of surgical patient care. The risk for venous thromboembolism in surgical patients can be stratified by their risk factors...

  • Unfractionated Heparin Three Times a Day versus Enoxaparin in the Prevention of Deep Vein Thrombosis in Trauma Patients. ARNOLD, JOSHUA D.; DART, BENJAMIN W.; BARKER, DONALD E.; MAXWELL, ROBERT A.; BURKHOLDER, HANS C.; MEJIA, VICENTE A.; SMITH, PHILIP W.; LONGLEY, JOY M. // American Surgeon;Jun2010, Vol. 76 Issue 6, p563 

    Venous thromboembolic disease is a significant source of morbidity and mortality in hospitalized trauma patients. Multiple drugs and dosing regimens have been suggested for pharmacoprophylaxis. In this study, we compared efficacy, complications, and cost of unfractionated heparin administered...

  • The use of prophylaxis in patients undergoing diagnostic tests for suspected venous thromboembolism. Lee, J. -A.; Zierler, B. K. // Phlebology;Apr2010, Vol. 25 Issue 2, p85 

    Objectives: The purpose of this study was to describe the use of pharmacological and mechanical prophylaxis and clinical outcomes of patients undergoing diagnostic tests for suspected venous thromboembolism (VTE). Methods: The medical records of 660 consecutive inpatients referred for suspected...

  • Thrombolytic therapy for pulmonary embolism. Katchan, Brian M.; Katchan, B M // Canadian Journal of Surgery;Dec2000, Vol. 43 Issue 6, p411 

    Consensus regarding the use of thrombolysis to treat acute pulmonary embolism has not yet been reached. There is good evidence that thrombolytic agents dissolve clot more rapidly than heparin. However, proving that this benefit reduces the death rate from pulmonary embolism has been difficult....

  • Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development Conference. Sherry, Sol; Bell, William R.; Duckert, F.H.; Fletcher, Anthony P.; Gurewich, Victor; Long, David M.; Marder, Victor J.; Roberts, Harold; Salzman, Edwin W.; Sasahara, Arthur; Verstraete, Marc // Annals of Internal Medicine;Jul80 Part 1, Vol. 93 Issue 1, p141 

    Editorial. Presents the consensus reached by a National Institutes of Health during a 1980 conference on thrombolytic therapy in thrombosis. Benefits for the use of thrombolytic therapy in acute deep-vein thrombosis and pulmonary embolism; Risks associated with the use of thrombolytic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics